Your browser doesn't support javascript.
loading
Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
Poupel, Lucie; Boissonnas, Alexandre; Hermand, Patricia; Dorgham, Karim; Guyon, Elodie; Auvynet, Constance; Charles, Flora Saint; Lesnik, Philippe; Deterre, Philippe; Combadiere, Christophe.
Affiliation
  • Poupel L; From UMR_S 945, Laboratoire "Immunité et Infection," Inserm Paris, France and Université Pierre et Marie Curie- (UPMC) Paris 6, Paris, France (L.P., A.B., P.H., K.D., E.G., C.A., P.D., C.C.); UMR_S 939 P.LUMR_S 939, Laboratoire "Dyslipidémies, Inflammation et Athérosclérose," Paris, France (F.S.C., P.L.); and AP-HP, Groupe Hospitalier Pitié-Salpétrière, Service d'Immunologie, Paris, France (C.C.).
Arterioscler Thromb Vasc Biol ; 33(10): 2297-305, 2013 Oct.
Article in En | MEDLINE | ID: mdl-23887641
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aorta / Aortic Diseases / Peptides / Receptors, Chemokine / Atherosclerosis / Chemokine CX3CL1 / Anti-Inflammatory Agents / Hypolipidemic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Arterioscler Thromb Vasc Biol Journal subject: ANGIOLOGIA Year: 2013 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aorta / Aortic Diseases / Peptides / Receptors, Chemokine / Atherosclerosis / Chemokine CX3CL1 / Anti-Inflammatory Agents / Hypolipidemic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Arterioscler Thromb Vasc Biol Journal subject: ANGIOLOGIA Year: 2013 Document type: Article